iOMEDICO AG
Industry / private company
Location:
Freiburg,
Germany (DE)
ISNI: -
ROR: https://ror.org/03j5af397
Show on Map:
Interim results from PAZOREAL: A non-interventional study to assess effectiveness and safety of pazopanib and everolimus in the changing mRCC treatment landscape (2017)
Bedke J, Welslau M, Boegemann M, Schostak M, Hering-Schubert C, Petzoldt A, Wolf T, et al.
Conference contribution
A Cross-Sectional Investigation of Fatigue, Mucositis, Hand-Foot Syndrome and Dysgeusia in Advanced Renal Cell Carcinoma Treatment: Final Results From the FAMOUS Study (2016)
Goebell P, Mueller L, Hurtz HJ, Koska M, Busies S, Marschner N
Journal article
SWITCH: A Randomised, Sequential, Open-label Study to Evaluate the Efficacy and Safety of Sorafenib-sunitinib Versus Sunitinib-sorafenib in the Treatment of Metastatic Renal Cell Cancer (2015)
Eichelberg C, Vervenne WL, De Santis M, Von Weikersthal LF, Goebell P, Lerchenmueller C, Zimmermann U, et al.
Journal article
A cross-sectional investigation of fatigue in advanced renal cell carcinoma treatment: results from the FAMOUS study (2014)
Goebell P, Muench A, Mueller L, Hurtz HJ, Koska M, Busies S, Marschner N
Journal article